Company / Total Assets
Minerva Neurosciences, Inc. Total Assets History
FY2017-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$37.1M
FY2024
5-year range
$37.1M / $77.1M
FY2020-FY2024
Trend
-34.7%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Total Assets has fluctuated over the past 8 years, ranging from $37M in FY2024 to $184M in FY2017.
Based on SEC 10-K filings.
$37M in FY2024 with a 5-year CAGR of -13.7%.
Declined from $55M to $37M over the past 2 years.
Total Assets over time
Growth rates
- 3-Year CAGR
- -21.6%
- 5-Year CAGR
- -13.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -13.7%, indicating a declining trend.
- In FY2024, total assets decreased 34.7% year-over-year.
- Peak total assets was recorded in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -10.64 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $37.1M | -34.7% |
| FY2023 | $56.9M | +3.3% |
| FY2022 | $55.1M | -28.6% |
| FY2021 | $77.1M | +33.8% |
| FY2020 | $57.6M | -25.6% |
| FY2019 | $77.5M | -44.3% |
| FY2018 | $139.1M | -24.3% |
| FY2017 | $183.7M | - |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026